Drug Price Transparency RAC

In August 2025, the Ninth Circuit issued an opinion in PhRMA v. Stolfi reversing the decision of the District Court that took effect on October 31, 2025. Accordingly, the department must resume collection of mandatory price increase reports from manufacturers in 2026. This rulemaking makes temporary rules permanent which resumes mandatory collection of required price increase reports from manufacturers due March 15 annually.

Rulemaking updates

Updates on the rulemaking process will appear here once Notice of Proposed Rulemaking has been filed.

• Hearing Officer Report
• Permanent filing
• Notice of Proposed Rulemaking
  

Public comment letters

• Public comments will be posted as they become available.

Committee Contacts

Lily Sobolik
Senior Policy Advisor
Lily.Sobolik@dcbs.oregon.gov
Phone: 971-446-8813

Karen Winkel
Rules Coordinator
Karen.J.Winkel@dcbs.oregon.gov
Phone: 503-947-7694